Stay informed with the latest updates for the inheritable blood disorders community.

NBDF & Community
2020 NYC Half Marathon Cancelled
2020 NYC Half Marathon Cancelled
COVID-19
NHF Office Response to COVID-19
NHF Office Response to COVID-19
NBDF & Community
Takeda Responds to HFA-NHF Letter on VONVENDI Recall
Takeda Responds to HFA-NHF Letter on VONVENDI Recall
COVID-19
NHF Letter to the Community on COVID-19
NHF Letter to the Community on COVID-19
NBDF & Community
MASAC Letter to the Community Regarding the Coronavirus Disease 2019
MASAC Letter to the Community Regarding the Coronavirus Disease 2019
NBDF & Community
Community Statement from Genentech on Hemlibra supply amid 2019-nCoV
Community Statement from Genentech on Hemlibra supply amid 2019-nCoV
NBDF & Community
Joint Statement on Recall of VONVENDI Lots
Joint Statement on Recall of VONVENDI Lots
NBDF & Community
Takeda announced a pharmacy-level recall of two lots of VONVENDI
Takeda announced a pharmacy-level recall of two lots of VONVENDI
NBDF & Community
Letter to the NHF Community
Letter to Our Community
NBDF & Community
How FDA is Putting the Patient Voice at the Forefront of Gene Therapy Clinical Trials for Hemophilia
How FDA is Putting the Patient Voice at the…
NBDF & Community
NHF Awarded 4-star Rating from Charity Navigator
NHF Awarded 4-star Rating from Charity Navigator
NBDF & Community
NHF, WFH, EHC Monitor Coronavirus Impact on Bleeding Disorders Community
NHF, WFH, EHC Monitor Coronavirus Impact on Bleeding Disorders Community
NBDF & Community
NHF and the Green Park Collaborative Launch Project to Measure Mental Health Outlook
NHF and the Green Park Collaborative Launch Project to Measure…
NBDF & Community
NHF/HFA Seek Feedback on Product Safety and Communication
NHF and HFA Hold Safety Summit
NBDF & Community
National Hemophilia Foundation Announces Next CEO
National Hemophilia Foundation Announces Next CEO